Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis
Nozima Aripova(Tashkent Pharmaceutical Institute), Ted R. Mikuls(Nebraska Medical Center)
Cited by 27
Related Papers
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3
|Arthritis & Rheumatology|2020|242
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1
|Arthritis & Rheumatology|2021|242
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3
|Arthritis & Rheumatology|2021|201